Anal carcinoma study

Phase 3

• Conditions: Anal carcinoma; Ananl carcinoma, Human papillomavirus; D001005

• Registration Number: JPRN-jRCTs032210649
• Lead Sponsor: Ando Naokatsu

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2022-03-07
• Last Update Posted: 22 January 2024

Recruitment & Eligibility

• Status: ot Recruiting
• Sex: All
• Target Recruitment: 20

Inclusion Criteria

(1) Subjects who have given written consent to participate in the study.
2) person aged 20 years or older.
3) Patients with a diagnosis of anal intraepithelial carcinoma or neoplasia based on the results of histological findings

Exclusion Criteria

1) Invasive cancer
2) Patients whom the principal investigator judges to be inappropriate for inclusion in the study.
3) pregnant or breastfeeding woman

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Eradication rate of anal carcinoma after 6 months

Secondary Outcome Measures

Name	Time	Method
Eradication rate of anal carcinoma after 3 months<br>The rate of complication after ablation therapy